PregLem SA
- Country
- 🇨🇭Switzerland
- Ownership
- Private, Subsidiary
- Established
- 2006-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.preglem.com
Non-interventional Study to Evaluate Long Term Safety, Prescription Management Patterns of Esmya in a Long Term Setting
- Conditions
- Uterine Fibroids
- First Posted Date
- 2016-04-22
- Last Posted Date
- 2019-10-16
- Lead Sponsor
- PregLem SA
- Target Recruit Count
- 1500
- Registration Number
- NCT02748460
- Locations
- 🇧🇪
Cliniques Universitaires Saint-Luc, Bruxelles, Belgium
🇧🇪Universitair Ziekenhuis Gent, Gent, Belgium
🇧🇪Centre Hospitalier Regional De La Citadelle, Liege, Belgium
PGL4001 Efficacy Assessment in Reduction of Symptoms Due to Uterine Leiomyomata
- First Posted Date
- 2012-07-17
- Last Posted Date
- 2016-01-08
- Lead Sponsor
- PregLem SA
- Target Recruit Count
- 64
- Registration Number
- NCT01642472
- Locations
- 🇦🇹
Medical University Vienna, Vienna, Austria
🇧🇪Cliniques Universitaires Saint-Luc, Gynécologie-Obstétrique,, Brussels, Belgium
🇧🇪CHR de la Citadelle, Liège, Belgium
A Prospective Multicenter Non-interventional Study of Women Treated With ESMYA (Ulipristal Acetate) as Pre-operative Treatment of Moderate to Severe Symptoms of Uterine Fibroids
- Conditions
- Uterine Fibroids
- First Posted Date
- 2012-07-09
- Last Posted Date
- 2015-01-27
- Lead Sponsor
- PregLem SA
- Target Recruit Count
- 1500
- Registration Number
- NCT01635452
- Locations
- 🇦🇹
LKH Klagenfurt, Klagenfurt, Austria
🇵🇱Private practice, Lublin, Poland
🇫🇷CHU Pellegrin Gynécologie, Bordeaux, France
PGL2001 Proof of Concept Study in Symptomatic Endometriosis
- Conditions
- Endometriosis
- Interventions
- Drug: PGL2001 + Primolut-Nor 5Drug: Placebo + Primolut-Nor 5
- First Posted Date
- 2012-06-29
- Last Posted Date
- 2014-06-03
- Lead Sponsor
- PregLem SA
- Target Recruit Count
- 162
- Registration Number
- NCT01631981
- Locations
- 🇭🇺
Synexus Magyarország Kft., Budapest, Hungary
🇭🇺Semmelweis Egyetem II. Szülészeti és Nőgyógyászati Klinika, Budapest, Hungary
🇭🇺Debreceni Egyetem Orvos-es Egeszsegtudomanyi Centrum Szuleszeti es Nogyogyaszati Klinika, Debrecen, Hungary
PGL5001 Proof of Concept Study in Inflammatory Endometriosis
- First Posted Date
- 2012-06-28
- Last Posted Date
- 2014-06-03
- Lead Sponsor
- PregLem SA
- Target Recruit Count
- 24
- Registration Number
- NCT01630252
- Locations
- 🇵🇱
Prywatna Klinika Połozniczo-Ginekologiczna Sp z o.o., Bialystok, Poland
PGL4001 Efficacy Assessment in Reduction of Symptoms Due to Uterine Leiomyomata
- Conditions
- Uterine Fibroids
- Interventions
- Drug: PGL4001 5 mgDrug: PGL4001 10 mg
- First Posted Date
- 2012-06-27
- Last Posted Date
- 2019-09-04
- Lead Sponsor
- PregLem SA
- Target Recruit Count
- 451
- Registration Number
- NCT01629563
- Locations
- 🇧🇪
Cliniques Universitaires Saint-Luc Gynécologie-Obstétrique, Brussels, Belgium
🇧🇪UZ Leuven Campus Gasthuisberg, Leuven, Belgium
🇧🇪CHU de Liège, CHR de la Citadelle Gynécologie-Obstétrique, Liège, Belgium
PGL4001 Efficacy Assessment in Reduction of Symptoms Due to Uterine Leiomyomata (PEARLIII-extension Study)
- Conditions
- Uterine Fibroids
- Interventions
- Drug: PGL4001, progestin, drug free periodDrug: PGL4001, placebo, drug free period
- First Posted Date
- 2010-12-02
- Last Posted Date
- 2016-01-13
- Lead Sponsor
- PregLem SA
- Target Recruit Count
- 132
- Registration Number
- NCT01252069
- Locations
- 🇦🇹
Medical University Vienna, department of obstetrics and gynecology, Vienna, Austria
🇧🇪Cliniques Universitaires Saint-Luc Gynécologie-Obstétrique, Bruxelles, Belgium
🇧🇪CHR de la Citadelle Gynécologie-Obstétrique, Liège, Belgium
PGL4001 Efficacy Assessment in Reduction of Symptoms Due to Uterine Leiomyomata
- Conditions
- Uterine Fibroids
- Interventions
- Drug: PGL4001, placeboDrug: PGL4001, progestin
- First Posted Date
- 2010-07-05
- Last Posted Date
- 2016-01-15
- Lead Sponsor
- PregLem SA
- Target Recruit Count
- 209
- Registration Number
- NCT01156857
- Locations
- 🇦🇹
Medical University Graz, department of obstetrics and gynecology, Graz, Austria
🇦🇹Medical University Vienna, department of obstetrics and gynecology, Vienna, Austria
🇧🇪Cliniques Universitaires Saint-Luc, Bruxelles, Belgium
PGL4001 Versus Placebo in Uterine Myomas
- Conditions
- Uterine Myomas
- Interventions
- Drug: PGL4001 matching placebo and ironDrug: PGL4001 (ulipristal) and iron
- First Posted Date
- 2008-09-19
- Last Posted Date
- 2012-12-13
- Lead Sponsor
- PregLem SA
- Target Recruit Count
- 241
- Registration Number
- NCT00755755
- Locations
- 🇨🇿
Gynekologicko-porodnicka klinika FN Brno, Brno, Czech Republic
🇨🇿Mediva, Praha, Czech Republic
🇨🇿Gynekologicko-porodnicka klinika 1.LF UK a VFN, Praha, Czech Republic
PGL4001 Versus GnRH-agonist in Uterine Myomas
- First Posted Date
- 2008-08-25
- Last Posted Date
- 2012-12-17
- Lead Sponsor
- PregLem SA
- Target Recruit Count
- 301
- Registration Number
- NCT00740831
- Locations
- 🇦🇹
Medical University Graz, Graz, Austria
🇦🇹Medical University of Innsbruck, Innsbruck, Austria
🇦🇹Landesklinikum Thermenregion Neunkirchen; Dept. For Gynecology, Neunkirchen, Austria